Lisa Sutter, 52, who works for the city government in Washington, D.C., lost weight on Belviq when she took it for two years during one of the drug's trials. At 5-foot-5, she dropped from 230 pounds to 190.
After the trial, Lisa Sutter regained all the weight she had lost and now worries about developing diabetes. The latest tool in the difficult battle against obesity may be on the market by early next year.